174 related articles for article (PubMed ID: 25965707)
1. Design and rationale of a prospective, collaborative meta-analysis of all randomized controlled trials of angiotensin receptor antagonists in Marfan syndrome, based on individual patient data: A report from the Marfan Treatment Trialists' Collaboration.
Pitcher A; Emberson J; Lacro RV; Sleeper LA; Stylianou M; Mahony L; Pearson GD; Groenink M; Mulder BJ; Zwinderman AH; De Backer J; De Paepe AM; Arbustini E; Erdem G; Jin XY; Flather MD; Mullen MJ; Child AH; Forteza A; Evangelista A; Chiu HH; Wu MH; Sandor G; Bhatt AB; Creager MA; Devereux RB; Loeys B; Forfar JC; Neubauer S; Watkins H; Boileau C; Jondeau G; Dietz HC; Baigent C
Am Heart J; 2015 May; 169(5):605-12. PubMed ID: 25965707
[TBL] [Abstract][Full Text] [Related]
2. Angiotensin receptor blockers and β blockers in Marfan syndrome: an individual patient data meta-analysis of randomised trials.
Pitcher A; Spata E; Emberson J; Davies K; Halls H; Holland L; Wilson K; Reith C; Child AH; Clayton T; Dodd M; Flather M; Jin XY; Sandor G; Groenink M; Mulder B; De Backer J; Evangelista A; Forteza A; Teixido-Turà G; Boileau C; Jondeau G; Milleron O; Lacro RV; Sleeper LA; Chiu HH; Wu MH; Neubauer S; Watkins H; Dietz H; Baigent C;
Lancet; 2022 Sep; 400(10355):822-831. PubMed ID: 36049495
[TBL] [Abstract][Full Text] [Related]
3. A prospective, randomized, placebo-controlled, double-blind, multicenter study of the effects of irbesartan on aortic dilatation in Marfan syndrome (AIMS trial): study protocol.
Mullen MJ; Flather MD; Jin XY; Newman WG; Erdem G; Gaze D; Valencia O; Banya W; Foley CE; Child A
Trials; 2013 Dec; 14():408. PubMed ID: 24289736
[TBL] [Abstract][Full Text] [Related]
4. Meta-analysis Examining the Usefulness of Angiotensin Receptor blockers for the Prevention of Aortic Root Dilation in Patients With the Marfan Syndrome.
Al-Abcha A; Saleh Y; Mujer M; Boumegouas M; Herzallah K; Charles L; Elkhatib L; Abdelkarim O; Kehdi M; Abela GS
Am J Cardiol; 2020 Aug; 128():101-106. PubMed ID: 32650901
[TBL] [Abstract][Full Text] [Related]
5. The effects of losartan versus beta-blockers on cardiovascular protection in marfan syndrome: A systematic review and meta-analysis.
Kang YN; Chi SC; Wu MH; Chiu HH
J Formos Med Assoc; 2020 Jan; 119(1 Pt 1):182-190. PubMed ID: 31003918
[TBL] [Abstract][Full Text] [Related]
6. A systematic review of the pharmacological management of aortic root dilation in Marfan syndrome.
Thakur V; Rankin KN; Hartling L; Mackie AS
Cardiol Young; 2013 Aug; 23(4):568-81. PubMed ID: 23083542
[TBL] [Abstract][Full Text] [Related]
7. Rationale and design of a trial evaluating the effects of losartan vs. nebivolol vs. the association of both on the progression of aortic root dilation in Marfan syndrome with FBN1 gene mutations.
Gambarin FI; Favalli V; Serio A; Regazzi M; Pasotti M; Klersy C; Dore R; Mannarino S; Viganò M; Odero A; Amato S; Tavazzi L; Arbustini E
J Cardiovasc Med (Hagerstown); 2009 Apr; 10(4):354-62. PubMed ID: 19430350
[TBL] [Abstract][Full Text] [Related]
8. Marfan Treatment Trialists' Collaboration in perspective: Sartans and beta-blockers in patients with Marfan syndrome.
Jondeau G; Milleron O; Eliahou L; Boileau C; Ropers J
Arch Cardiovasc Dis; 2023 Apr; 116(4):173-175. PubMed ID: 36964091
[No Abstract] [Full Text] [Related]
9. Angiotensin II blockade and aortic-root dilation in Marfan's syndrome.
Brooke BS; Habashi JP; Judge DP; Patel N; Loeys B; Dietz HC
N Engl J Med; 2008 Jun; 358(26):2787-95. PubMed ID: 18579813
[TBL] [Abstract][Full Text] [Related]
10. The future of Cochrane Neonatal.
Soll RF; Ovelman C; McGuire W
Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
[TBL] [Abstract][Full Text] [Related]
11. Rationale and design of a randomized clinical trial (Marfan Sartan) of angiotensin II receptor blocker therapy versus placebo in individuals with Marfan syndrome.
Detaint D; Aegerter P; Tubach F; Hoffman I; Plauchu H; Dulac Y; Faivre LO; Delrue MA; Collignon P; Odent S; Tchitchinadze M; Bouffard C; Arnoult F; Gautier M; Boileau C; Jondeau G
Arch Cardiovasc Dis; 2010 May; 103(5):317-25. PubMed ID: 20619242
[TBL] [Abstract][Full Text] [Related]
12. Do angiotensin receptor blockers prevent cardiac events in patients with Marfan syndrome?
Su PY; Chiu HH; Kang YN
Eur J Prev Cardiol; 2020 Dec; 27(19):2067-2068. PubMed ID: 31660748
[No Abstract] [Full Text] [Related]
13. Effect of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers on all-cause mortality, cardiovascular deaths, and cardiovascular events in patients with diabetes mellitus: a meta-analysis.
Cheng J; Zhang W; Zhang X; Han F; Li X; He X; Li Q; Chen J
JAMA Intern Med; 2014 May; 174(5):773-85. PubMed ID: 24687000
[TBL] [Abstract][Full Text] [Related]
14. Drug-based cardiovascular prevention in patients with Marfan Syndrome: a systematic review.
Pavasini R; Sanguettoli F; Deserio MA; Bianchi N; Zanarelli L; Fabbri G; Tonet E; Passarini G; Serenelli M; Campo G
Minerva Cardiol Angiol; 2023 Dec; 71(6):611-621. PubMed ID: 36939732
[TBL] [Abstract][Full Text] [Related]
15. The Ghent Marfan Trial--a randomized, double-blind placebo controlled trial with losartan in Marfan patients treated with β-blockers.
Möberg K; De Nobele S; Devos D; Goetghebeur E; Segers P; Trachet B; Vervaet C; Renard M; Coucke P; Loeys B; De Paepe A; De Backer J
Int J Cardiol; 2012 Jun; 157(3):354-8. PubMed ID: 21239069
[TBL] [Abstract][Full Text] [Related]
16. Angiotensin Receptor Blockers vs. Beta-Blocker Therapy for Marfan Syndrome: A Systematic Review and Meta-Analysis.
Wang Z; Deng X; Kang X; Hu A
Ann Vasc Surg; 2022 May; 82():347-361. PubMed ID: 34998935
[TBL] [Abstract][Full Text] [Related]
17. Recent Clinical Drug Trials Evidence in Marfan Syndrome and Clinical Implications.
Singh MN; Lacro RV
Can J Cardiol; 2016 Jan; 32(1):66-77. PubMed ID: 26724512
[TBL] [Abstract][Full Text] [Related]
18. Protocol for prospective collaborative overviews of major randomized trials of blood-pressure-lowering treatments. World Health Organization-International Society of Hypertension Blood Pressure Lowering Treatment Trialists' Collaboration.
J Hypertens; 1998 Feb; 16(2):127-37. PubMed ID: 9535138
[TBL] [Abstract][Full Text] [Related]
19. Details of a prospective protocol for a collaborative meta-analysis of individual participant data from all randomized trials of intravenous rt-PA vs. control: statistical analysis plan for the Stroke Thrombolysis Trialists' Collaborative meta-analysis.
Stroke Thrombolysis Trialists' Collaborative Group
Int J Stroke; 2013 Jun; 8(4):278-83. PubMed ID: 23639145
[TBL] [Abstract][Full Text] [Related]
20. Effect of perindopril on large artery stiffness and aortic root diameter in patients with Marfan syndrome: a randomized controlled trial.
Ahimastos AA; Aggarwal A; D'Orsa KM; Formosa MF; White AJ; Savarirayan R; Dart AM; Kingwell BA
JAMA; 2007 Oct; 298(13):1539-47. PubMed ID: 17911499
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
